These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4772960)

  • 1. Comparative investigations of the enzyme-inducing activity of rifampicin and barbiturates in man.
    Nitti V; Ninni A; Meola G; Iuliano A; Curci G
    Chemotherapy; 1973 Oct; 19(4):206-10. PubMed ID: 4772960
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interactions between phenprocoumon (Marcumar) and drug-catabolizing, enzyme system-inducing pharmaceutic agents].
    Heni N; Völger R; Glogner P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1579-82. PubMed ID: 347786
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
    Ohnhaus EE; Kirchhof B; Peheim E
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic studies on rifampicin. III. Effect of phenobarbital on the half-life of the antibiotic.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Nicolis FB
    Tijdschr Gastroenterol; 1974; 17(3):151-8. PubMed ID: 4454053
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired enzyme induction by rifampicin in the elderly.
    Twum-Barima Y; Finnigan T; Habash AI; Cape RD; Carruthers SG
    Br J Clin Pharmacol; 1984 May; 17(5):595-7. PubMed ID: 6733008
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme induction and beta-adrenergic receptor blocking drugs.
    Branch RA; Herman RJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):77S-84S. PubMed ID: 6146342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of three different enzyme inducing agents and their influence on plasma lipids in man [proceedings].
    Ohnhaus EE
    Br J Clin Pharmacol; 1977 Jun; 4(3):398P. PubMed ID: 901724
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rifampin pretreatment on hepatic parameters in the rabbit.
    Whitehouse LW; Iverson F; Wong LT
    Toxicol Lett; 1985; 24(2-3):131-6. PubMed ID: 3983965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofibrate and enzymatic induction in man.
    Houin G; Tillement JP
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):150-4. PubMed ID: 649234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of barbiturate derivatives on the serum bilirubin of the Gunn rat.
    Schmid H; Ballowitz L
    Eur J Pediatr; 1984 Jun; 142(2):151. PubMed ID: 6147252
    [No Abstract]   [Full Text] [Related]  

  • 12. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
    Larousse C; Kergueris MF; Le Normand Y; Visset J
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bilirubin and hepatic enzyme induction.
    Scott AK; Jeffers TA; Petrie JC; Gilbert JC
    Br Med J; 1979 Aug; 2(6185):310. PubMed ID: 476443
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis therapy and enzyme induction in man.
    Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on blood serum levels of rifampicin in patients with normal and impaired liver function.
    Curci G; Claar E; Bergamini N; Ninni A; Claar GM; Ascione A; Nitti V
    Chemotherapy; 1973 Oct; 19(4):197-205. PubMed ID: 4772959
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Drugs affecting oral contraceptives.
    Mumford JP
    Br Med J; 1974 May; 2(5914):333-4. PubMed ID: 4827122
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor.
    Chen Y; Ferguson SS; Negishi M; Goldstein JA
    J Pharmacol Exp Ther; 2004 Feb; 308(2):495-501. PubMed ID: 14600250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-life of rifampicin after repeated administration of different doses in humans.
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Chemotherapy; 1972; 17(6):373-81. PubMed ID: 5082603
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical implications of enzyme induction and enzyme inhibition.
    Park BK; Breckenridge AM
    Clin Pharmacokinet; 1981; 6(1):1-24. PubMed ID: 6113907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunotropic activity of GABA during cytochrome P-450 induction in the liver].
    Kovalev IE; Riabinina NE
    Farmakol Toksikol; 1989; 52(2):53-5. PubMed ID: 2744145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.